CDSCO flags 2 drugs as spurious, another 111 fail quality test in Nov ’24

The Central Drugs Standard Control Organisation (CDSCO) on Friday flagged select batches of two drugs as spurious and listed 111 other drugs and formulations as not of standard quality (NSQ).
The samples flagged as spurious in CDSCO’s recent monthly update for November 2024 include popular drugs Pan D and the antibiotic Augmentin 625 Duo, which are marketed by Alkem Laboratories and GlaxoSmithKline Pharma, respectively.
While the CDSCO alert has named the brands for which spurious samples were found, it does not name the drug manufacturers.
“The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious; however, the same is subject to the outcome of the investigation,” the replies state.
“These drugs have been made by unauthorised and unknown manufacturers using brand names owned by other companies. An investigation has been initiated in the matter,” the Union Health Ministry stated in a note.

Related Posts

  • Pharma
  • February 1, 2025
  • 218 views
Stricter Rules Soon To Curb Pregabalin, Tapentadol Sales Amid Rising Drug Abuse

New Delhi:  Two painkiller medicines are under the scanner of the Union government following reports of drug abuse. Last year, the apex drug regulatory body of India — Central Drugs…

  • Pharma
  • February 1, 2025
  • 133 views
Nonopioid Drug For Acute Pain Wins FDA Approval

Boston:  A long-awaited nonopioid pain drug won approval yesterday from the U.S. Food and Drug Administration (FDA) to treat moderate to severe short-term pain. Suzetrigine, an oral drug marketed by Vertex…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Union Budget 2025 pleased Healthcare Leaders except for a Letdown or two

Union Budget 2025 pleased Healthcare Leaders except for a Letdown or two

Stricter Rules Soon To Curb Pregabalin, Tapentadol Sales Amid Rising Drug Abuse

Stricter Rules Soon To Curb Pregabalin, Tapentadol Sales Amid Rising Drug Abuse

Nonopioid Drug For Acute Pain Wins FDA Approval

Nonopioid Drug For Acute Pain Wins FDA Approval

One Thousand Narcotic Injections Seized From Biker In Palwal

One Thousand Narcotic Injections Seized From Biker In Palwal